Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management bought 15,390 shares of the stock in a transaction on Friday, February 13th. The stock was acquired at an average cost of $1.89 per share, for a total transaction of $29,087.10. Following the acquisition, the insider directly owned 633,700 shares in the company, valued at approximately $1,197,693. The trade was a 2.49% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Thursday, February 12th, Glenbrook Capital Management acquired 7,956 shares of Senestech stock. The stock was acquired at an average cost of $1.72 per share, with a total value of $13,684.32.
- On Wednesday, February 11th, Glenbrook Capital Management acquired 8,000 shares of Senestech stock. The stock was bought at an average price of $1.73 per share, for a total transaction of $13,840.00.
- On Thursday, February 5th, Glenbrook Capital Management bought 2,884 shares of Senestech stock. The shares were bought at an average cost of $1.77 per share, for a total transaction of $5,104.68.
- On Wednesday, February 4th, Glenbrook Capital Management purchased 5,685 shares of Senestech stock. The stock was bought at an average cost of $1.82 per share, with a total value of $10,346.70.
- On Monday, February 2nd, Glenbrook Capital Management purchased 42,739 shares of Senestech stock. The stock was bought at an average price of $1.98 per share, for a total transaction of $84,623.22.
- On Friday, January 30th, Glenbrook Capital Management acquired 5,399 shares of Senestech stock. The shares were bought at an average cost of $1.87 per share, with a total value of $10,096.13.
Senestech Stock Performance
Shares of NASDAQ SNES traded up $0.22 during mid-day trading on Friday, hitting $2.00. The company had a trading volume of 44,882 shares, compared to its average volume of 45,234. Senestech, Inc. has a 12 month low of $1.30 and a 12 month high of $6.24. The firm has a market cap of $10.44 million, a P/E ratio of -0.55 and a beta of 0.21. The business’s 50-day simple moving average is $2.19 and its 200-day simple moving average is $3.44. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Senestech in a report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold”.
Read Our Latest Analysis on Senestech
Institutional Trading of Senestech
Several large investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC raised its stake in shares of Senestech by 35.2% in the fourth quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock valued at $306,000 after acquiring an additional 37,165 shares during the last quarter. DRW Securities LLC grew its position in Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock worth $176,000 after acquiring an additional 51,818 shares during the last quarter. Sabby Management LLC acquired a new stake in Senestech during the 3rd quarter valued at $313,000. Corsair Capital Management L.P. bought a new position in Senestech in the 2nd quarter valued at $255,000. Finally, Jane Street Group LLC bought a new position in Senestech in the 2nd quarter valued at $161,000. 5.19% of the stock is owned by institutional investors.
About Senestech
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Read More
- Five stocks we like better than Senestech
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
